Epstein Secrets

ump aimed to take credit for the speedy development of forthcoming coronavirus vaccines at a White House summit Tuesday." The New Ynrk Time (12/7, LaFraniere, Thomas, Weiland, 18.61M) reports the Pfizer- BioNTech vaccine is "a two-dose treatment, meaning that 100 million doses is enough to vaccinate only

use other countries have rushed to buy up most of its supply, according to multiple individuals familiar with the situation." While The Hilt (12/7, Weixel, 2.98M) reports an Administration official "said nobody turned down additional Pfizer doses" and said the US "has contracts with five other companie

2/07/world/covid-19-coronavirustitrump- administration-officials-passed-when-pfizer-offered-in-late-summer-to-sell-the-us-more-vaccine-doses> (12/7, LaFraniere, Thomas, Weiland, 18.61 M) reports the Pfizer-BioNTech vaccine is "a two-dose treatment, meaning that 100 million doses is enough to vaccinate only

n." While The Hill <https://thehill.com/policy/healthcare/529131-trump-officials-deny-turning-down-additional- doses-of-pfizer-covid-vaccine> (12/7, Weixel, 2.98M) reports an Administration official "said nobody turned down additional Pfizer doses" and said the US "has contracts with five other companie

ump aimed to take credit for the speedy development of forthcoming coronavirus vaccines at a White House summit Tuesday." The New York Times (12/7, LaFraniere, Thomas, Weiland, 18.61M) reports the Pfizer- BioNTech vaccine is "a two-dose treatment, meaning that 100 million doses is enough to vaccinate only

se other countries have rushed to buy up most of its supply, according to multiple individuals familiar with the situation." While The Hill (12/7, Weixel, 2.98M) reports an Administration official "said nobody turned down additional Pfizer doses" and said the US "has contracts with five other companie

"Nationwide, 12,000 vaccination sites are up and running, an increase from 1,000 three weeks ago." However, the New York Times (1/5, Al, Stolberg, LaFraniere, 20.6M) reports that federal officials "and drugmakers, faced with a slower-than-expected rollout of the coronavirus vaccine, are racing to find wa

departments' inoculation of medical workers, while threatening to take away unused vaccines from hospitals slow to administer them." The Hill (1/5, Weixel, 5.69M) provides similar coverage. California Has Only Administered A Third Of Its Available Vaccine Doses. The AP (1/5, Ronayne) reports that "dis